Challenges in GPCR Drug Discovery
May 26, 2026 @ 09:00 – 17:00 CEST
G protein-coupled receptors (GPCRs) are the largest protein family encoded by the human genome and one of the key targets for therapeutic approaches across many disease areas. However, only around 25% of the druggable GPCRs have been tapped into. This presents a significant opportunity to develop novel medicines with high therapeutic impact for the GPCR class in numerous indications.
The Challenges in GPCR drug discovery workshop is co-organized by Gothenburg University, Uppsala University, and AstraZeneca to explore the latest advancements in GPCR drug discovery research. Our aim is to bring together renowned international experts from industry, biotech, academia and service providers to facilitate communication between scientific groups and research areas within GPCR drug discovery community. The workshop focusses on lead-generation aspects such as, computational approaches, structural biology and pharmacology in early drug discovery of GPCRs. We believe this will lead to uncovering common challenges and finding new innovative approaches to drug discovery for GPCRs, and further strengthen the GPCR community in the Nordics.
The workshop has a maximum of 90 attendants generating an informal atmosphere encouraging discussions, networking and information exchange. Participants are encouraged to submit poster abstracts. Registration deadline is 27th of April. Due to the limited number of seats, with over-subscription the organizing committee will maintain the right to select participants on the basis of fit to the program, participants with a poster contribution will be prioritized, otherwise selections in order of registration.
Venue
AstraZeneca Gothenburg, Pepparedsleden 1, 431 53, Mölndal
Participants are welcomed to report at the reception at the main entrance (KC)
Confirmed Speakers
Asoc. Prof. Dr. Martin Gustavsson, Asoc. Prof. Dr. Elisabeth Rexen Ulven, Asoc. Prof. Dr Alexander Hauser (Copenhagen University), Dr. Janosch Ehrenma (LeadXpro), Andreas Kiessling, PhD (Project Manager, Cube-Biotech)
Organizing committee
- Linda Johansson, Gothenburg University
- Jens Carlsson, Uppsala University
- Arjan Snijder, AstraZeneca
This workshop is sponsored by: Cube Biotech
Flyer

